RayKnowChina Research Map
Shortlist

Blood disorders

Haemophagocytic lymphohistiocytosis

噬血细胞性淋巴组织细胞增生症HLH

A group of related disorders marked by increased lymphocytes and histiocytes and by haemophagocytosis. The two main forms are inherited (primary) and acquired (secondary).

Definition adapted from MeSH (US National Library of Medicine)

Listed in China's second national rare-disease catalogue (2023). The catalogue lists the narrower entry “familial haemophagocytic lymphohistiocytosis”. National Health Commission 国卫医政发〔2023〕26号

hospitals in mainland China
66

with a paper from 2016–2025 or a registered study

cities
32

where those hospitals are

open trials in China
11

ClinicalTrials.gov, 8 Nov 2026

Mainland China accounts for 29% of the world's English-language research papers on haemophagocytic lymphohistiocytosis, 2021–2025 (18% in 2016–2020), and 38% of the world's registered trials on it have a site in China.

Research activity in public records, not a rating of care and not medical advice. How the numbers are made

66 hospitals in 32 cities

Order: papers led on haemophagocytic lymphohistiocytosis, 2021–2025, then A–Z. Research activity, not a rating of care.

A hospital is listed when it led at least 2 papers or 1 trial on haemophagocytic lymphohistiocytosis, or was a site in 2 or more trials. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first. Hospitals not listed may also treat it. Definitions

A square is a city. Its size and number are hospitals listed for this disease, not the amount of research. Choose one to show that city in the hospital list and the trial list.

Cities with the most listed hospitals

  1. Beijing11
  2. Guangzhou5
  3. Shanghai5
  4. Changsha4
  5. Chongqing4
  6. Hangzhou4
  7. Chengdu3
  8. Jinan2
  9. Shijiazhuang2
  10. Suzhou2

Each opens haemophagocytic lymphohistiocytosis in that city. 22 more cities are in the menu below.

  1. 52 papers led
  2. 31 papers led
  3. Jiangsu Province Hospital

    江苏省人民医院(南医大一附院)Nanjing

    22 papers led
    No open trial led
  4. Tongji Hospital

    华中科技大学同济医学院附属同济医院WuhanInternational Medical Department

    20 papers led
  5. First Affiliated Hospital, Zhejiang University

    浙江大学医学院附属第一医院Hangzhou

    14 papers led
    No open trial led
  6. 12 papers led
    No open trial led
  7. 9 papers led
    No open trial led
  8. 8 papers led
    No open trial led
  9. Union Hospital

    华中科技大学同济医学院附属协和医院Wuhan

    8 papers led
    No open trial led
  10. 7 papers led
    No open trial led
  11. 7 papers led
  12. West China Second University Hospital

    四川大学华西第二医院Chengdu

    7 papers led
    No open trial led
  13. 6 papers led
    No open trial led
  14. 6 papers led
  15. Third Xiangya Hospital

    中南大学湘雅三医院Changsha

    6 papers led
    No open trial led
  16. 5 papers led
    No open trial led
  17. 5 papers led
    No open trial led
  18. 4 papers led
    No open trial led
  19. Sun Yat-sen Memorial Hospital

    中山大学孙逸仙纪念医院Guangzhou

    4 papers led
    No open trial led
  20. 3 papers led
    No open trial led
  21. 3 papers led
    No open trial led
  22. 3 papers led
    No open trial led
  23. 3 papers led
    No open trial led
  24. 3 papers led
    No open trial led
  25. Renji Hospital

    上海交通大学医学院附属仁济医院Shanghai

    3 papers led
    No open trial led
  26. 2 papers led
    No open trial led
  27. 2 papers led
    No open trial led
  28. Beijing Anzhen Hospital

    首都医科大学附属北京安贞医院Beijing

    2 papers led
    No open trial led
  29. Beijing Youan Hospital, Capital Medical University

    首都医科大学附属北京佑安医院Beijing

    2 papers led
    No open trial led
  30. 2 papers led
    No open trial led
  31. Chinese PLA General Hospital

    中国人民解放军总医院Beijing

    2 papers led
  32. 2 papers led
    No open trial led
  33. District People's Hospital

    济南市章丘区人民医院Jinan

    2 papers led
    No open trial led
  34. 2 papers led
    No open trial led
  35. 2 papers led
    No open trial led
  36. 2 papers led
    No open trial led
  37. First Hospital of China Medical University

    中国医科大学附属第一医院Shenyang

    2 papers led
    No open trial led
  38. 2 papers led
    No open trial led
  39. Fourth Hospital of Sichuan University

    四川大学华西医学中心Chengdu

    2 papers led
    No open trial led
  40. 2 papers led
    No open trial led
  41. Hainan General Hospital / Hainan Medical University hospitals

    海南医学院附属医院/海南省人民医院Haikou

    2 papers led
    No open trial led
  42. 2 papers led
    No open trial led
  43. Ruijin Hospital

    上海交通大学医学院附属瑞金医院Shanghai

    2 papers led
    No open trial led
  44. 2 papers led
    No open trial led
  45. 2 papers led
    No open trial led
  46. 2 papers led
    No open trial led
  47. Second Xiangya Hospital

    中南大学湘雅二医院Changsha

    2 papers led
    No open trial led
  48. 2 papers led
    No open trial led
  49. Shunde Women and Children's Hospital

    广东医科大学顺德妇女儿童医院(佛山市顺德区妇幼保健院)Foshan

    2 papers led
    No open trial led
  50. Southwest Hospital, Army Medical University

    陆军军医大学第一附属医院(西南医院)Chongqing

    2 papers led
    No open trial led
  51. Tangdu Hospital

    空军军医大学唐都医院Xi'an

    2 papers led
    No open trial led
  52. 2 papers led
    No open trial led
  53. 1 paper led
    No open trial led
  54. Beijing Tongren Hospital

    首都医科大学附属北京同仁医院Beijing

    1 paper led
  55. 1 paper led
    No open trial led
  56. 1 paper led
    No open trial led
  57. 1 paper led
    No open trial led
  58. 1 paper led
    No open trial led
  59. 1 paper led
    No open trial led
  60. 1 paper led
    No open trial led
  61. 1 paper led
    No open trial led
  62. 1 paper led
    No open trial led
  63. Xiangya Hospital

    中南大学湘雅医院Changsha

    1 paper led
    No open trial led
  64. 1 paper led
    No open trial led
  65. 0 papers led
    No open trial led
  66. Huadong Hospital, Fudan University

    复旦大学附属华东医院Shanghai

    0 papers led
    No open trial led

By university or health system 33

Hospitals carrying a university’s name, added together, plus papers that name only the university. Same order as above.

  1. Capital Medical University

    首都医科大学Beijing

    89 papers led
    6 hospitals
  2. Huazhong Univ. of Sci. & Tech. – Tongji Medical College

    华中科技大学同济医学院Wuhan

    28 papers led
    2 hospitals
  3. Zhejiang University School of Medicine

    浙江大学医学院Hangzhou

    26 papers led
    6 hospitals
  4. Nanjing Medical University

    南京医科大学Nanjing

    25 papers led
    5 hospitals
  5. Sichuan University (West China)

    四川大学华西Chengdu

    20 papers led
    3 hospitals
  6. Soochow University

    苏州大学Suzhou

    12 papers led
    3 hospitals
  7. Chongqing Medical University

    重庆医科大学Chongqing

    10 papers led
    4 hospitals
  8. Peking Union Medical College / Chinese Academy of Medical Sciences

    北京协和医学院/中国医学科学院Beijing

    10 papers led
    3 hospitals
  9. Central South University (Xiangya)

    中南大学湘雅Changsha

    9 papers led
    3 hospitals
  10. Peking University Health Science Center

    北京大学医学部Beijing

    9 papers led
    3 hospitals
  11. Sun Yat-sen University

    中山大学Guangzhou

    9 papers led
    5 hospitals
  12. Shanghai Jiao Tong University School of Medicine

    上海交通大学医学院Shanghai

    8 papers led
    5 hospitals
  13. Anhui Medical University

    安徽医科大学Hefei

    5 papers led
    3 hospitals
  14. Army Medical University

    陆军军医大学Chongqing

    5 papers led
    3 hospitals
  15. Nanchang University

    南昌大学Nanchang

    5 papers led
    1 hospital
  16. Zhengzhou University

    郑州大学Zhengzhou

    5 papers led
    3 hospitals
  17. Hebei Medical University

    河北医科大学Shijiazhuang

    4 papers led
    5 hospitals
  18. Jilin University

    吉林大学Changchun

    4 papers led
    1 hospital
  19. Qingdao University

    青岛大学Qingdao

    4 papers led
    2 hospitals
  20. Shandong University

    山东大学Jinan

    4 papers led
    3 hospitals
  21. Southern Medical University

    南方医科大学Guangzhou

    4 papers led
    3 hospitals
  22. Guangxi Medical University

    广西医科大学Nanning

    3 papers led
    1 hospital
  23. Nantong University

    南通大学Nantong

    3 papers led
    1 hospital
  24. Xuzhou Medical University

    徐州医科大学Xuzhou

    3 papers led
    1 hospital
  25. Air Force Medical University

    空军军医大学Xi'an

    2 papers led
    1 hospital
  26. China Medical University (Shenyang)

    中国医科大学Shenyang

    2 papers led
    1 hospital
  27. Chinese PLA General Hospital

    中国人民解放军总医院Beijing

    2 papers led
    1 hospital
  28. Fudan University

    复旦大学Shanghai

    2 papers led
    2 hospitals
  29. Guangdong Medical University

    广东医科大学Zhanjiang

    2 papers led
    1 hospital
  30. Guangzhou Medical University

    广州医科大学Guangzhou

    2 papers led
    2 hospitals
  31. Nanjing University

    南京大学Nanjing

    2 papers led
    2 hospitals
  32. University of Chinese Academy of Sciences

    中国科学院大学Beijing

    2 papers led
    1 hospital
  33. Wenzhou Medical University

    温州医科大学Wenzhou

    0 papers led
    0 hospitals

11

open trials on haemophagocytic lymphohistiocytosis in China

Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 8 Nov 2026, with at least one listed hospital as lead sponsor or site. 10 of them are led by a listed hospital. Check the registry for the current status. Whether someone can take part is decided by the study team.

Trials registered only in China’s own registry (ChiCTR) are not included. Questions to check before asking about a trial

What the phases mean (US National Cancer Institute)

  1. Recruiting
    Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)
    Phase
    Phase 1/Phase 2
    Started
    2026-04
    Registry
    NCT07525466

    Age 18 years to Not stated (registered criteria)

    Led by Beijing Tongren HospitalBeijing

  2. Recruiting
    Hemophagocytic Lymphohistiocytosis After Allogeneic Stem Cell Transplantation
    Phase
    Not given
    Started
    2026-10
    Registry
    NCT07905066

    Age 18 years to Not stated (registered criteria)

    Led by Peking University People's HospitalBeijing

  3. Recruiting
    A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])
    Phase
    Phase 3
    Started
    2025-11
    Registry
    NCT07208058

    Age 16 years to 80 years (registered criteria)

    Lead sponsor is not a listed hospital; 12 listed hospitals as study sitesBeijing, Guangzhou, Hangzhou, Nanchang, Shanghai, Shenyang, Shijiazhuang, Wuhan, Zhengzhou

  4. Recruiting
    Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
    Phase
    Phase 4
    Started
    2025-11
    Registry
    NCT07270835

    Age 14 years to 80 years (registered criteria)

    Led by First Affiliated Hospital of Soochow UniversitySuzhou

  5. Recruiting
    Prospective Single-Arm Clinical Trial of GO Regimen for HLH.
    Phase
    Phase 2/Phase 3
    Started
    2025-06
    Registry
    NCT07339345

    Age 14 years to 70 years (registered criteria)

    Led by Beijing Friendship HospitalBeijing

  6. Recruiting
    Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis
    Phase
    N/A
    Started
    2025-10
    Registry
    NCT07488728

    Age Not stated to 18 years (registered criteria)

    Led by Beijing Children's HospitalBeijing

  7. Recruiting
    Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection
    Phase
    Phase 1
    Started
    2023-08
    Registry
    NCT06135922

    Age 1 year to 60 years (registered criteria)

    Led by Chinese PLA General HospitalBeijing

  8. Recruiting
    Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection
    Phase
    Not given
    Started
    2019-07
    Registry
    NCT03491605

    Age not stated (registered criteria)

    Led by Tongji HospitalWuhan

  9. Not yet recruiting
    Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis
    Phase
    Phase 2/Phase 3
    Started
    2025-06
    Registry
    NCT06951971

    Age 1 year to 70 years (registered criteria)

    Led by First Affiliated Hospital of Soochow UniversitySuzhou

  10. Not yet recruiting
    Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections
    Phase
    N/A
    Started
    2023-08
    Registry
    NCT05988177

    Age 18 years to Not stated (registered criteria)

    Led by Beijing Friendship HospitalBeijing

  11. Not yet recruiting
    Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement
    Phase
    Not given
    Started
    2023-12
    Registry
    NCT06131489

    Age 18 years to Not stated (registered criteria)

    Led by Beijing Friendship HospitalBeijing

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

Before contacting a hospital

The same for every disease, so it is kept on one page. Each hospital page also has an enquiry letter in English and Chinese, and a name card to show staff.

Where these numbers come from

Papers

399 English-language PubMed papers on haemophagocytic lymphohistiocytosis with an author in mainland China, 2021–2025; a hospital led a paper when its first or last author lists it first. Run the PubMed search

Trials

ClinicalTrials.gov records with a listed hospital as lead sponsor or site, as of 8 Nov 2026. ChiCTR is not included. Search ClinicalTrials.gov

Locations

Locations are shown at city centres. Check the hospital’s website for its address.

Suggest a correctionDownload the data (CSV)Definitions